Adenocarcinoma Clinical Trials

A listing of Adenocarcinoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Gilbert Arizona 85234

Project Survival-Prospective Biomarker Discovery

UPDATED

Phoenix Arizona 85054

Project Survival-Prospective Biomarker Discovery

UPDATED

Scottsdale Arizona 85258

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

UPDATED

Scottsdale Arizona 85258

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

California

UPDATED

Bakersfield California 93309

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

UPDATED

Encinitas California 92024

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

UPDATED

Fullerton California 92835

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

UPDATED

La Jolla California 92037-0845

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

UPDATED

La Jolla California 92093

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

View More ▼

UPDATED

La Jolla California 92037-0845

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

UPDATED

La Jolla California 92093

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

UPDATED

Los Angeles California

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

UPDATED

Los Angeles California 90095

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

UPDATED

Rancho Mirage California 92262

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

UPDATED

Redondo Beach California 90277

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

UPDATED

San Diego California 92103

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

UPDATED

San Diego California 92103

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

UPDATED

San Francisco California 94115

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

UPDATED

Santa Barbara California 93105

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

UPDATED

Santa Maria California 93454

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

UPDATED

Santa Monica California

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

Colorado

UPDATED

Aurora Colorado 80045

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

UPDATED

Aurora Colorado 80045

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

UPDATED

Aurora Colorado 80045

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

Connecticut

UPDATED

New Haven Connecticut

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

UPDATED

New Haven Connecticut 06510

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

UPDATED

New Haven Connecticut 06520

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

UPDATED

New Haven Connecticut 06520

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

UPDATED

Norwalk Connecticut 6856

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

View More ▼

UPDATED

Norwich Connecticut 6360

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

Florida

UPDATED

Miami Florida 33133

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

UPDATED

Orlando Florida 32806

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

UPDATED

Pembroke Pines Florida 33028

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

UPDATED

Tampa Florida

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

UPDATED

Tampa Florida 33612

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

View More ▼

UPDATED

Tampa Florida 33606

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

Illinois

UPDATED

Chicago Illinois

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

UPDATED

Harvey Illinois 60426

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

UPDATED

Joliet Illinois 60435

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

UPDATED

Park Ridge Illinois 60068

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

Indiana

UPDATED

Indianapolis Indiana 46237

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

Iowa

UPDATED

Cedar Rapids Iowa 52403

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

Kansas

UPDATED

Topeka Kansas 66604

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

UPDATED

Westwood Kansas 66205

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

Louisiana

UPDATED

Metairie Louisiana 70006

A Phase 3 clinical study for patients with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction (JAVELIN Gastric 100)

Maryland

UPDATED

Baltimore Maryland

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

UPDATED

Baltimore Maryland 21231-2410

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

UPDATED

Baltimore Maryland 21287

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

UPDATED

Baltimore Maryland 21231

A Phase 1 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma, mPDAC

Massachusetts

UPDATED

Boston Massachusetts 02114-3117

A clinical trial seeking patients for a research study of LY2875358 and Ramucirumab